Posted by
Mavenclad Approved for Multiple Sclerosis

Mavenclad Approved for Multiple Sclerosis

MONDAY, April 1, 2019 (HealthDay News) — Mavenclad (cladribine) tablets have been approved by the U.S. Food and Drug Administration to treat relapsing multiple sclerosis (MS) in adults. Latest Neurology News An agency news release said the drug is recommended for people who have had an inadequate response to, or are unable to tolerate, another […]

Posted by
Scientists locate brain circuit that curbs overeating

Scientists locate brain circuit that curbs overeating

The brain has complex circuitry that locks appetite to memories of finding and enjoying food. This drives the feeding behaviors necessary for survival. New research reveals that the circuits include one mechanism that does the opposite: curbing the compulsion to eat in response to food. ‘People may be able to learn to change their relationship […]

Posted by
Questions Remain About Safety of Parkinson’s Psychosis Drug: Report

Questions Remain About Safety of Parkinson’s Psychosis Drug: Report

There are many unanswered questions about the safety and effectiveness of a drug used to combat hallucinations and delusions in Parkinson’s patients, says a report from a drug safety group. Latest Neurology News The nonprofit Institute for Safe Medication Practices (ISMP) called for Nuplazid to have stronger warnings on its label for patients and their […]

Posted by
14 Signs and Symptoms of Stroke (FAST)

14 Signs and Symptoms of Stroke (FAST)

What is a stroke? A stroke occurs when the blood supply to an area of the brain is cut off. The symptoms depend upon the region of the brain that is affected by the loss of blood supply and can include changes in sensation or motor control. Symptoms of a stroke also depend on how […]

Posted by
Music may enhance the effect of pain relievers

Music may enhance the effect of pain relievers

Bob Marley once said, “One good thing about music, when it hits you, you feel no pain.” A recent study using a mouse model backs up Marley’s musing with some scientific data. Listening to Mozart might boost pain medication. In the past, scientists have explored the idea of using music as a therapy in a […]

Posted by
Stroke vs. Mini-Stroke (TIA)

Stroke vs. Mini-Stroke (TIA)

Stroke vs. mini-stroke (TIA) quick comparison between differences Mini-stroke (transient ischemic attack, TIA) and stroke usually are caused by blockage of an artery in the brain, and less often by bleeding into the brain tissue. Strokes usually are classified as either ischemic or hemorrhagic. The causes of strokes and min-strokes (transient ischemic attack, TIA) are […]

Posted by
This drug failed to treat cancer, but it could improve dementia

This drug failed to treat cancer, but it could improve dementia

Dementia — an umbrella term for various neurodegenerative conditions involving memory loss and other forms of cognitive impairment — is hard to treat because its causes remain unknown. Researchers, however, are making painstaking progress. A new approach to dementia research may bring us closer to a treatment, but unexpected challenges could halt this progress. Dr. […]

Posted by
Multiple Sclerosis Early Symptoms and Signs (Early, Body Areas Affected)

Multiple Sclerosis Early Symptoms and Signs (Early, Body Areas Affected)

What is multiple sclerosis (MS)? At what age does multiple sclerosis start? Does multiple sclerosis cause pain? 5 early signs and symptoms of multiple sclerosis Sexual problems Bladder and bowel problems Speech and swallowing problems Balance, thinking, and emotional problems Vision problems Muscle, movement, and spasticity problems Numbness, tingling, and pain What are the treatment […]

Posted by
Mayzent Approved for Relapsing MS

Mayzent Approved for Relapsing MS

WEDNESDAY, March 27, 2019 (HealthDay News) — Mayzent (siponimod) pills have been approved by the U.S. Food and Drug Administration for adults with relapsing multiple sclerosis (MS). Latest Neurology News “Multiple sclerosis can have a profound impact on a person’s life,” said Dr. Billy Dunn, director of the agency’s Division of Neurology Products. MS is […]

Posted by
Common MS Treatment Can Bring Longer, Healthier Life

Common MS Treatment Can Bring Longer, Healthier Life

By Serena GordonHealthDay Reporter Latest Neurology News THURSDAY, March 28, 2019 (HealthDay News) — An older but still common multiple sclerosis (MS) treatment has an unexpected perk: It not only quells symptoms, but patients may also live longer. New research revealed that patients taking a beta interferon drug for more than three years were likely […]